141 related articles for article (PubMed ID: 31312501)
1. A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation.
Abdelhameed AS; Attwa MW; Al-Shaklia NS; Kadi AA
R Soc Open Sci; 2019 Jun; 6(6):190434. PubMed ID: 31312501
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation.
Attwa MW; Abdelhameed AS; Kadi AA
Drug Des Devel Ther; 2021; 15():3915-3925. PubMed ID: 34552321
[TBL] [Abstract][Full Text] [Related]
4. Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation.
Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903565
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies.
Attwa MW; Kadi AA; Abdelhameed AS; Alhazmi HA
Drug Des Devel Ther; 2020; 14():783-793. PubMed ID: 32158196
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.
AlRabiah H; Kadi AA; Attwa MW; Mostafa GAE
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1154():122195. PubMed ID: 32943176
[TBL] [Abstract][Full Text] [Related]
7. Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability.
Abdelhameed AS; Kadi AA; Attwa MW; AlRabiah H
PLoS One; 2019; 14(4):e0214598. PubMed ID: 30947315
[TBL] [Abstract][Full Text] [Related]
8. Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.
Attwa MW; AlRabiah H; Mostafa GAE; Bakheit AH; Kadi AA
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985590
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry.
Attwa MW; Kadi AA; Darwish HW
Drug Des Devel Ther; 2020; 14():111-119. PubMed ID: 32021096
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes.
Attwa MW; AlRabiah H; Kadi AA
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903615
[TBL] [Abstract][Full Text] [Related]
11. A simple liquid chromatography-tandem mass spectrometry method to accurately determine the novel third-generation EGFR-TKI naquotinib with its applicability to metabolic stability assessment.
Alrabiah H; Kadi AA; Attwa MW; Abdelhameed AS
RSC Adv; 2019 Feb; 9(9):4862-4869. PubMed ID: 35514667
[TBL] [Abstract][Full Text] [Related]
12. Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS.
Attwa MW; Al-Shakliah NS; AlRabiah H; Kadi AA; Abdelhameed AS
J Pharm Biomed Anal; 2022 Mar; 211():114626. PubMed ID: 35123331
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay.
Attwa MW; Abdelhameed AS; Al-Shakliah NS; Kadi AA
Drug Des Devel Ther; 2020; 14():4439-4449. PubMed ID: 33122888
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the irreversible fibroblast growth factor receptor inhibitor futibatinib by UPLC-MS/MS: Application to the metabolic stability assay in human liver microsomes for the estimation of its in vitro hepatic intrinsic clearance.
Tang LWT; Chan ECY
J Pharm Biomed Anal; 2022 May; 214():114731. PubMed ID: 35325798
[TBL] [Abstract][Full Text] [Related]
15. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
[TBL] [Abstract][Full Text] [Related]
16. A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomes.
Attwa MW; Abdelhameed AS; Alsaif NA; Kadi AA; AlRabiah H
RSC Adv; 2022 Jul; 12(31):20387-20394. PubMed ID: 35919584
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation.
Amer SM; Kadi AA; Darwish HW; Attwa MW
Chem Cent J; 2017 May; 11(1):45. PubMed ID: 29086823
[TBL] [Abstract][Full Text] [Related]
18. A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate.
Attwa MW; Kadi AA; Darwish HW; Amer SM; Alrabiah H
Eur J Mass Spectrom (Chichester); 2018 Aug; 24(4):344-351. PubMed ID: 29629565
[TBL] [Abstract][Full Text] [Related]
19. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rate.
Amer SM; Kadi AA; Darwish HW; Attwa MW
Chem Cent J; 2017 Dec; 11(1):136. PubMed ID: 29274040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
